期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
High-throughput drug screening models of mature adipose tissues which replicate the physiology of patients’Body Mass Index(BMI) 被引量:1
1
作者 Fiona Louis Yoshihiro Sowa +1 位作者 Shiro Kitano Michiya Matsusaki 《Bioactive Materials》 SCIE 2022年第1期227-241,共15页
Obesity is a complex and incompletely understood disease,but current drug screening strategies mostly rely on immature in vitro adipose models which cannot recapitulate it properly.To address this issue,we developed a... Obesity is a complex and incompletely understood disease,but current drug screening strategies mostly rely on immature in vitro adipose models which cannot recapitulate it properly.To address this issue,we developed a statistically validated high-throughput screening model by seeding human mature adipocytes from patients,encapsulated in physiological collagen microfibers.These drop tissues ensured the maintenance of adipocyte viability and functionality for controlling glucose and fatty acids uptake,as well as glycerol release.As such,patients’BMI and insulin sensitivity displayed a strong inverse correlation:the healthy adipocytes were associated with the highest insulin-induced glucose uptake,while insulin resistance was confirmed in the underweight and severely obese adipocytes.Insulin sensitivity recovery was possible with two type 2 diabetes treatments,rosiglitazone and melatonin.Finally,the addition of blood vasculature to the model seemed to more accurately recapitulate the in vivo physiology,with particular respect to leptin secretion metabolism. 展开更多
关键词 Mature vascularized adipose tissue reconstruction High-throughput drug-screening model OBESITY BMI Diabetes
原文传递
An RNA polymerase I-driven human respiratory syncytial virus minigenome as a tool for quantifying virus titers and screening antiviral drug
2
作者 Yuan-Hui Fu Ya-Ru Liu +5 位作者 Yan-Peng Zheng Nan Jiang Yue-Ying-Jiao Wei Li Xiang-Lei Peng Jin-Sheng He 《Chinese Chemical Letters》 SCIE CAS CSCD 2017年第1期131-135,共5页
Human respiratory syncytial virus(RSV) is an important pediatric pathogen of lower respiratory tract worldwide. No vaccines and antiviral drugs are available. Herein the use of an RNA polymerase I-driven RSV minigen... Human respiratory syncytial virus(RSV) is an important pediatric pathogen of lower respiratory tract worldwide. No vaccines and antiviral drugs are available. Herein the use of an RNA polymerase I-driven RSV minigenome for analyzing RSV replication and screening anti-RSV drugs was investigated. The RNA polymerase I(Pol I) was used to transcribe RSV minigenome from the constructed plasmid, designated p HM-RSV-Gluc, of minigenome c DNA which comprised trailer region, gene start sequence(GS), reverse complementary copy of Gaussia luciferase(Gluc) gene, gene end sequence(GE), and leader region in the direction of 5'–3'end and was flanked by promoter and terminator of Pol I. The expression of Gluc was confirmed in p HM-RSV-Gluc transfected HEp-2 cells following RSV infection and had the characteristics of dose-dependent, which provided a rapid, sensitive, and quantitative method for quantifying virus titers and screening antiviral drugs. 展开更多
关键词 Human respiratory syncytial virus Gaussia luciferase MINIGENOME Antiviral drug drug-screening
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部